← ANALYSTS · TIPRANKS
David Dai · UBS
Hits
59%
43 of 73 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+9.3%
Over a year after the rating, TipRanks’ measure
Our companies rated now
13
Buy / hold / sell: 10 / 3 / 0
Upside of the analyst’s targets
+69.5%
Average over 13 current targets, to the last price
The market’s answer to the ratings
+3.2%
Day-0 move against SPY in the rating’s direction, average over 6 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 2on TipRanks Oct 3 09:35 | CATXIWMPerspective Therapeutics · $267M | Reiterated | Buy | $8.00 | +268.7% | +0.7%next day −7.6% · 5 days −4.8% | ↗ |
| Sep 28on TipRanks Sep 29 06:25 | SMMTSummit Therapeutics · $12.4B | Reiterated | Buy | $33.00 | +125.6% | −0.1%next day +6.1% · 5 days +10.4% | ↗ |
| Sep 16on TipRanks 07:55 | ENGNenGene Holdings · $115M | Assigned | Hold | $2.00 | +19.8% | +1.5%next day −1.1% · 5 days +2.6% | ↗ |
| Sep 16on TipRanks 04:50 | BNTXBioNTech SE · $24.1B | Reiterated | Buy | $135 | +53.9% | −0.4%next day +1.8% · 5 days +0.7% | ↗ |
| Aug 21on TipRanks 07:55 | KURAIWMKura Oncology · $863M | Assigned | Buy | $15.00 | +65.2% | +1.1%next day +4.6% · 5 days +6.0% | ↗ |
| Aug 21on TipRanks 07:20 | SNDXIWMSyndax Pharmaceuticals · $1.2B | Assigned | Buy | $37.00 → $33.00−10.8% | +155.8% | −0.9%next day −0.1% · 5 days −1.0% | ↗ |
| Aug 21on TipRanks Aug 20 07:35 | CGONIWMCG Oncology, Inc. · $5.5B | Assigned | Buy | $90.00 | +50.4% | −3.0%next day +2.4% · 5 days +0.7% | ↗ |
| Aug 20on TipRanks 06:11 | IOVAIWMIovance Biotherapeutics · $6.7B | Assigned | Hold | $4.00 → $7.00+75.0% | −48.6% | +13.4%next day −8.2% · 5 days −9.2% | ↗ |
| Aug 17on TipRanks 08:55 | CGEMIWMCullinan Management · $901M | Reiterated | Buy | $24.00 → $27.00+12.5% | +108.8% | +1.7%next day +1.9% · 5 days +7.2% | ↗ |
| Aug 5on TipRanks Aug 6 06:50 | KYMRIWMKymera Therapeutics · $9.0B | Reiterated | Buy | $128 | +22.2% | +1.2%next day +1.0% · 5 days +7.8% | ↗ |
| Jul 22on TipRanks 21:03 | NRIXIWMNurix Therapeutics · $2.7B | Assigned | Buy | $23.00 → $31.00+34.8% | +26.9% | +1.8%next day −1.6% · 5 days −1.1% | ↗ |
| Jun 16on TipRanks Jun 18 07:45 | CLDXIWMCelldex · $2.3B | Reiterated | Buy | $45.00 | +63.5% | +1.2%next day +3.1% · 5 days +6.5% | ↗ |
| Apr 15on TipRanks 05:25 | JANXIWMJanux Therapeutics Inc · $1.1B | Downgrade | Hold | $57.00 → $15.00−73.7% | −9.1% | −2.1%next day +0.8% · 5 days +0.7% | ↗ |
| Mar 18on TipRanks 08:10 | CATXIWMPerspective Therapeutics · $267M | Assigned | Buy | $7.00 → $8.00+14.3% | +268.7% | −0.4%next day −5.1% · 5 days −6.6% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗